HISTEX-DM New Formulation 20 mg/5mL
DEXTROMETHORPHAN HBr, PSEUDOEPHEDRINE HCI, and TRIPROLIDINE HCI · SYRUP · Allegis Pharmaceuticals, LLC
HISTEX-DM New Formulation is a syrup containing dextromethorphan hbr, pseudoephedrine hci, and triprolidine hci at 20 mg/5mL, taken oral. Manufactured by Allegis Pharmaceuticals, LLC.
Key Facts
- Brand Name
- HISTEX-DM New Formulation
- Generic Name
- DEXTROMETHORPHAN HBr, PSEUDOEPHEDRINE HCI, and TRIPROLIDINE HCI
- NDC Code (Product)
28595-310- Manufacturer
- Allegis Pharmaceuticals, LLC
- Strength
- 20 mg/5mL
- Dosage Form
- SYRUP
- Route
- ORAL
- Marketing Status
- Application #
- M012
- Marketing Start
- 03/10/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is HISTEX-DM New Formulation used for?
HISTEX-DM New Formulation contains DEXTROMETHORPHAN HBr, PSEUDOEPHEDRINE HCI, and TRIPROLIDINE HCI. It is a syrup taken oral. Consult your doctor for specific uses.
Is HISTEX-DM New Formulation a controlled substance?
HISTEX-DM New Formulation is not classified as a controlled substance by the DEA.
What is the generic name for HISTEX-DM New Formulation?
The generic name for HISTEX-DM New Formulation is DEXTROMETHORPHAN HBr, PSEUDOEPHEDRINE HCI, and TRIPROLIDINE HCI. There are no other listed brand versions of DEXTROMETHORPHAN HBr, PSEUDOEPHEDRINE HCI, and TRIPROLIDINE HCI.
What is the NDC code for HISTEX-DM New Formulation 20 mg/5mL?
The NDC (National Drug Code) for HISTEX-DM New Formulation 20 mg/5mL is 28595-310, listed by Allegis Pharmaceuticals, LLC.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)